Clinical Trials

994 enrolled 10 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT03221426 2026-03-09

KEYNOTE-585

1,007 enrolled 25 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT05116189 2026-03-09

KEYNOTE-B96

643 enrolled 17 charts 1 FDA

Other solid neoplasmThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07246863 2026-03-04

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Phase 2 Recruiting

131 enrolled

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06888921 2026-02-27

MAIA-ovarian

Phase 1/2 Recruiting

60 enrolled

Ovarian Neoplasms

NCT03635567 2026-02-04

KEYNOTE-826

617 enrolled 29 charts 1 FDA

LymphoidOther hematologic neoplasm

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT05645107 2025-12-16

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Phase 3 Recruiting

386 enrolled

Agammaglobulinemia, Bacterial Infections, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07237425 2025-12-04

Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

Phase 1 Recruiting

56 enrolled

Lipoma

NCT03740165 2025-10-22

KEYLYNK-001

1,367 enrolled 29 charts

Phase 2 Not yet recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT07219459 2025-10-21

GDFATHERHCC01

104 enrolled

Carcinoma, Hepatocellular

NCT05951777 2025-09-29

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Phase 2 Recruiting

51 enrolled

Lymphoid

Brain Injuries, Traumatic, Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Trauma, Nervous System, Intracranial Hemorrhages

NCT05933577 2025-09-24

V940-001

1,089 enrolled

Dermatologic

Melanoma

NCT05394714 2025-09-23

A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study

Phase 1 Recruiting

18 enrolled

Colonic Neoplasms

NCT03834493 2025-07-18

KEYNOTE-641

1,244 enrolled 21 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

1,030 enrolled 24 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

806 enrolled 32 charts

Prostatic Neoplasms

NCT03515837 2024-11-22

MK-3475-789

492 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT04210115 2024-11-15

KEYNOTE 975

703 enrolled

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

NCT02578680 2024-09-20

MK-3475-189

616 enrolled 19 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT04799249 2024-08-01

PRESERVE 2

194 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03950674 2024-06-10

MK-3475-189

40 enrolled 20 charts

Phase 2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT05493800 2024-05-29

Capella

60 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Stomatitis, Hematologic Neoplasms

NCT04571645 2024-04-15

AML

Phase 3 Terminated

9 enrolled 9 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02663622 2024-01-23

MK-7110-002

Other hematologic neoplasm

44 enrolled 27 charts

Graft vs Host Disease, Leukemia

NCT05794659 2023-07-20

Cornerstone4

Phase 2 Not yet recruiting

98 enrolled

Advanced Ovarian Cancer

NCT03066778 2022-10-03

KEYNOTE-604

453 enrolled 23 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT01956812 2021-08-16

PANCRIT®-1

Phase 3 Terminated

334 enrolled

Pancreatic Neoplasms

NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Phase 2 Terminated

76 enrolled 25 charts

Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02453334 2021-05-11

IRON CLAD

244 enrolled 33 charts

Tumor-Agnostic

Neoplasms

NCT01687387 2019-02-08

EFFIKIR

Other hematologic neoplasm

152 enrolled 9 charts

Leukemia, Myeloid, Acute

NCT00614393 2018-08-08

Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)

558 enrolled 17 charts

Colorectal Neoplasms

NCT00738699 2017-03-30

FAR-122

Phase 2 Terminated

415 enrolled 11 charts

Ovarian Neoplasms

NCT00850577 2015-10-12

Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer

Phase 2 Terminated

255 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00851045 2015-10-12

Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

17 enrolled

Colorectal Neoplasms

NCT01579188 2012-04-19

LucaVax

Phase 3 Unknown

600 enrolled

Inoperable Stage III Non-small Cell Lung Cancer

NCT00951574 2012-02-01

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)